A mostrar 1 - 2 resultados de 2 para a pesquisa 'R. Rampal', tempo de pesquisa: 0.02seg Refinar resultados
  1. 1
    P1054: MYLOX-1: AN OPEN-LABEL, PHASE IIA STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR, GB2064, IN MYELOFIBROSIS

    P1054: MYLOX-1: AN OPEN-LABEL, PHASE IIA STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF ORAL LOXL2 INHIBITOR, GB2064, IN MYELOFIBROSIS Por C. Harrison, J. Mascarenhas, R. Rampal, D. Cilloni, B. Lindmark, B. Singh, B. Jacoby, S. Verstovsek

    Publicado em 2022-06-01
    Obter o texto integral
    Artigo
  2. 2
    P1063: EFFICACY AND SAFETY OF PARSACLISIB-RUXOLITINIB COMBINATION THERAPY IN MYELOFIBROSIS PATIENTS WITH LOW VS HIGHER BASELINE PLATELET COUNT: A SUBGROUP ANALYSIS OF DATA FROM A PHASE 2 STUDY

    P1063: EFFICACY AND SAFETY OF PARSACLISIB-RUXOLITINIB COMBINATION THERAPY IN MYELOFIBROSIS PATIENTS WITH LOW VS HIGHER BASELINE PLATELET COUNT: A SUBGROUP ANALYSIS OF DATA FROM A P... Por A. Yacoub, U. Borate, R. Rampal, H. Ali, E. Wang, A. Gerds, G. Hobbs, M. Kremyanskaya, E. Winton, C. O’Connell, S. Goel, S. Oh, G. Schiller, A. Assad, S. Erickson-Viitanen, F. Zhou, N. Daver

    Publicado em 2022-06-01
    Obter o texto integral
    Artigo

Ferramentas de pesquisa: